Cargando…

Improving Patient Outcomes While Reducing Empirical Treatment with Multiplex-Polymerase-Chain-Reaction/Pooled-Antibiotic-Susceptibility-Testing Assay for Complicated and Recurrent Urinary Tract Infections

This study compared rates of empirical-therapy use and negative patient outcomes between complicated and recurrent urinary tract infection (r/cUTI) cases diagnosed with a multiplex polymerase chain reaction or pooled antibiotic susceptibility testing (M-PCR/P-AST) vs. standard urine culture (SUC). S...

Descripción completa

Detalles Bibliográficos
Autores principales: Haley, Emery, Luke, Natalie, Korman, Howard, Baunoch, David, Wang, Dakun, Zhao, Xinhua, Mathur, Mohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573050/
https://www.ncbi.nlm.nih.gov/pubmed/37835804
http://dx.doi.org/10.3390/diagnostics13193060
_version_ 1785120375840964608
author Haley, Emery
Luke, Natalie
Korman, Howard
Baunoch, David
Wang, Dakun
Zhao, Xinhua
Mathur, Mohit
author_facet Haley, Emery
Luke, Natalie
Korman, Howard
Baunoch, David
Wang, Dakun
Zhao, Xinhua
Mathur, Mohit
author_sort Haley, Emery
collection PubMed
description This study compared rates of empirical-therapy use and negative patient outcomes between complicated and recurrent urinary tract infection (r/cUTI) cases diagnosed with a multiplex polymerase chain reaction or pooled antibiotic susceptibility testing (M-PCR/P-AST) vs. standard urine culture (SUC). Subjects were 577 symptomatic adults (n = 207 males and n = 370 females) presenting to urology/urogynecology clinics between 03/30/2022 and 05/24/2023. Treatment and outcomes were recorded by the clinician and patient surveys. The M-PCR/P-AST (n = 252) and SUC (n = 146) arms were compared after patient matching for confounding factors. The chi-square and Fisher’s exact tests were used to analyze demographics and clinical outcomes between study arms. Reduced empirical-treatment use (28.7% vs. 66.7%), lower composite negative events (34.5% vs. 46.6%, p = 0.018), and fewer individual negative outcomes of UTI-related medical provider visits and UTI-related visits for hospitalization/an urgent care center/an emergency room (p < 0.05) were observed in the M-PCR/P-AST arm compared with the SUC arm. A reduction in UTI symptom recurrence in patients ≥ 60 years old was observed in the M-PCR/P-AST arm (p < 0.05). Study results indicate that use of the M-PCR/P-AST test reduces empirical antibiotic treatment and negative patient outcomes in r/cUTI cases.
format Online
Article
Text
id pubmed-10573050
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105730502023-10-14 Improving Patient Outcomes While Reducing Empirical Treatment with Multiplex-Polymerase-Chain-Reaction/Pooled-Antibiotic-Susceptibility-Testing Assay for Complicated and Recurrent Urinary Tract Infections Haley, Emery Luke, Natalie Korman, Howard Baunoch, David Wang, Dakun Zhao, Xinhua Mathur, Mohit Diagnostics (Basel) Article This study compared rates of empirical-therapy use and negative patient outcomes between complicated and recurrent urinary tract infection (r/cUTI) cases diagnosed with a multiplex polymerase chain reaction or pooled antibiotic susceptibility testing (M-PCR/P-AST) vs. standard urine culture (SUC). Subjects were 577 symptomatic adults (n = 207 males and n = 370 females) presenting to urology/urogynecology clinics between 03/30/2022 and 05/24/2023. Treatment and outcomes were recorded by the clinician and patient surveys. The M-PCR/P-AST (n = 252) and SUC (n = 146) arms were compared after patient matching for confounding factors. The chi-square and Fisher’s exact tests were used to analyze demographics and clinical outcomes between study arms. Reduced empirical-treatment use (28.7% vs. 66.7%), lower composite negative events (34.5% vs. 46.6%, p = 0.018), and fewer individual negative outcomes of UTI-related medical provider visits and UTI-related visits for hospitalization/an urgent care center/an emergency room (p < 0.05) were observed in the M-PCR/P-AST arm compared with the SUC arm. A reduction in UTI symptom recurrence in patients ≥ 60 years old was observed in the M-PCR/P-AST arm (p < 0.05). Study results indicate that use of the M-PCR/P-AST test reduces empirical antibiotic treatment and negative patient outcomes in r/cUTI cases. MDPI 2023-09-26 /pmc/articles/PMC10573050/ /pubmed/37835804 http://dx.doi.org/10.3390/diagnostics13193060 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Haley, Emery
Luke, Natalie
Korman, Howard
Baunoch, David
Wang, Dakun
Zhao, Xinhua
Mathur, Mohit
Improving Patient Outcomes While Reducing Empirical Treatment with Multiplex-Polymerase-Chain-Reaction/Pooled-Antibiotic-Susceptibility-Testing Assay for Complicated and Recurrent Urinary Tract Infections
title Improving Patient Outcomes While Reducing Empirical Treatment with Multiplex-Polymerase-Chain-Reaction/Pooled-Antibiotic-Susceptibility-Testing Assay for Complicated and Recurrent Urinary Tract Infections
title_full Improving Patient Outcomes While Reducing Empirical Treatment with Multiplex-Polymerase-Chain-Reaction/Pooled-Antibiotic-Susceptibility-Testing Assay for Complicated and Recurrent Urinary Tract Infections
title_fullStr Improving Patient Outcomes While Reducing Empirical Treatment with Multiplex-Polymerase-Chain-Reaction/Pooled-Antibiotic-Susceptibility-Testing Assay for Complicated and Recurrent Urinary Tract Infections
title_full_unstemmed Improving Patient Outcomes While Reducing Empirical Treatment with Multiplex-Polymerase-Chain-Reaction/Pooled-Antibiotic-Susceptibility-Testing Assay for Complicated and Recurrent Urinary Tract Infections
title_short Improving Patient Outcomes While Reducing Empirical Treatment with Multiplex-Polymerase-Chain-Reaction/Pooled-Antibiotic-Susceptibility-Testing Assay for Complicated and Recurrent Urinary Tract Infections
title_sort improving patient outcomes while reducing empirical treatment with multiplex-polymerase-chain-reaction/pooled-antibiotic-susceptibility-testing assay for complicated and recurrent urinary tract infections
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573050/
https://www.ncbi.nlm.nih.gov/pubmed/37835804
http://dx.doi.org/10.3390/diagnostics13193060
work_keys_str_mv AT haleyemery improvingpatientoutcomeswhilereducingempiricaltreatmentwithmultiplexpolymerasechainreactionpooledantibioticsusceptibilitytestingassayforcomplicatedandrecurrenturinarytractinfections
AT lukenatalie improvingpatientoutcomeswhilereducingempiricaltreatmentwithmultiplexpolymerasechainreactionpooledantibioticsusceptibilitytestingassayforcomplicatedandrecurrenturinarytractinfections
AT kormanhoward improvingpatientoutcomeswhilereducingempiricaltreatmentwithmultiplexpolymerasechainreactionpooledantibioticsusceptibilitytestingassayforcomplicatedandrecurrenturinarytractinfections
AT baunochdavid improvingpatientoutcomeswhilereducingempiricaltreatmentwithmultiplexpolymerasechainreactionpooledantibioticsusceptibilitytestingassayforcomplicatedandrecurrenturinarytractinfections
AT wangdakun improvingpatientoutcomeswhilereducingempiricaltreatmentwithmultiplexpolymerasechainreactionpooledantibioticsusceptibilitytestingassayforcomplicatedandrecurrenturinarytractinfections
AT zhaoxinhua improvingpatientoutcomeswhilereducingempiricaltreatmentwithmultiplexpolymerasechainreactionpooledantibioticsusceptibilitytestingassayforcomplicatedandrecurrenturinarytractinfections
AT mathurmohit improvingpatientoutcomeswhilereducingempiricaltreatmentwithmultiplexpolymerasechainreactionpooledantibioticsusceptibilitytestingassayforcomplicatedandrecurrenturinarytractinfections